Industry trends

Purchasing information

Home page

Industry trends

Aprotinin returns to the market or endangers public life

Aprotinin was recalled to the global market due to the results of BART research. Recently, the relevant personnel of this research said that the decision of European and Canadian regulatory authorities to allow aprotinin to return to the market or the risk of endangering public life safety exists.

2017-07-18

Fosun Pharmaceuticals acquired 74% equity of Gland74 to build an international platform for preparations

Today, the company announced that it signed the Third Amendment with the existing shareholders and related parties of India Gland, adjusting the transaction to: the company invested no more than US $1091.3 million to acquire about 74% of Gland's equity, including the contingent consideration paid for the listing and sale of Gland Enoxaparin in the United States, which did not exceed US $25 million. The termination date of this transaction is extended to October 3, 2017.

2017-09-20

< 1 2 3 4 5 >

Panoramic Analysis of China's Foreign Trade in Medical Devices in 2015

2017-07-18

Do you know that some medicines need to be protected from light? If you don't know, just take a look

2017-07-18

Aprotinin returns to the market or endangers public life

2017-07-18

Fosun Pharmaceuticals acquired 74% equity of Gland74 to build an international platform for preparations

2017-09-20

Top 20 accounts for more than 75%! Take a closer look at the leading varieties in the 100 billion level cardiovascular and cerebrovascular drug market

2017-10-09

Policy Interpretation of the Announcement on the Evaluation of the Quality and Efficacy Consistency of Generic Drugs

2017-10-11

图片名称

©2022 Jiangxi Runquankang Biotechnology Co., Ltd. All rights reserved

| SEO | Technical support:300.cn

图片名称

图片名称

Address: Guantian Industrial Park, Chongyi , Ganzhou, Jiangxi

图片名称

Tel：0791-88610177

图片名称

Phone：15170676666

图片名称

Mail：info@rqkpharm.com

图片名称

图片名称

Scan code to view